TNSN98138A1 - Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse - Google Patents
Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basseInfo
- Publication number
- TNSN98138A1 TNSN98138A1 TNTNSN98138A TNSN98138A TNSN98138A1 TN SN98138 A1 TNSN98138 A1 TN SN98138A1 TN TNSN98138 A TNTNSN98138 A TN TNSN98138A TN SN98138 A TNSN98138 A TN SN98138A TN SN98138 A1 TNSN98138 A1 TN SN98138A1
- Authority
- TN
- Tunisia
- Prior art keywords
- motority
- benzamide derivatives
- low gastrointestinal
- stimulating
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
L'INVENTION CONCERNE DES COMPOSES DE FORMULE GENERALE (I) SUIVANTE :DANS LAQUELLE n = 1 OU 2, R1 EST UN GROUPE ALKYLE OU CYCLOALKYLE, R2 ET R3 REPRESENTENT H, OH, OU UN GROUPE CYCLOALKYLE. L'INVENTION CONCERNE EGALEMENT LES COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES, ET LEUR UTILISATION DANS LE CADRE DU TRAITEMENT DES DYSFONCTIONNEMENTS DU TUBE DIGESTIF HAUT ET BAS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9709477A FR2766484B1 (fr) | 1997-07-25 | 1997-07-25 | Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN98138A1 true TNSN98138A1 (fr) | 2005-03-15 |
Family
ID=9509623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN98138A TNSN98138A1 (fr) | 1997-07-25 | 1998-07-15 | Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0998458A1 (fr) |
AR (1) | AR014900A1 (fr) |
AU (1) | AU8867898A (fr) |
CO (1) | CO4990994A1 (fr) |
FR (1) | FR2766484B1 (fr) |
TN (1) | TNSN98138A1 (fr) |
WO (1) | WO1999005106A1 (fr) |
ZA (1) | ZA986633B (fr) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE620543A (fr) * | ||||
GB1015921A (en) * | 1961-10-06 | 1966-01-05 | Benger Lab Ltd | Benzamides |
AR216043A1 (es) * | 1974-03-21 | 1979-11-30 | Anphar Sa | Procedimiento para la preparacion de 1-derivados de benzoilamino-4-piperidina y sus sales fisiologicamente aceptables |
WO1987002584A1 (fr) * | 1985-10-25 | 1987-05-07 | The Upjohn Company | Anti-convulsifs a l'acetamide et a la benzamide de cis-n-(2-aminocycloaliphatique)benzene |
FR2674849B1 (fr) * | 1991-04-02 | 1994-12-23 | Logeais Labor Jacques | Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique. |
WO1993003725A1 (fr) * | 1991-08-20 | 1993-03-04 | Smithkline Beecham Plc | Antagonistes du recepteur 5-ht4 |
AU2075295A (en) * | 1994-03-14 | 1995-10-03 | Sanofi | Use of 4-amino-5-chloro-2-methoxybenzoic esters as 5-ht4 agonists |
FR2735693B1 (fr) * | 1995-06-23 | 1997-09-26 | Logeais Labor Jacques | Nouvelles applications therapeutiques de n-cyclohexyl benzamides |
-
1997
- 1997-07-25 FR FR9709477A patent/FR2766484B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-15 TN TNTNSN98138A patent/TNSN98138A1/fr unknown
- 1998-07-24 AR ARP980103645A patent/AR014900A1/es unknown
- 1998-07-24 EP EP98940329A patent/EP0998458A1/fr not_active Withdrawn
- 1998-07-24 AU AU88678/98A patent/AU8867898A/en not_active Abandoned
- 1998-07-24 WO PCT/FR1998/001640 patent/WO1999005106A1/fr not_active Application Discontinuation
- 1998-07-24 ZA ZA986633A patent/ZA986633B/xx unknown
- 1998-07-24 CO CO98042280A patent/CO4990994A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU8867898A (en) | 1999-02-16 |
FR2766484A1 (fr) | 1999-01-29 |
FR2766484B1 (fr) | 1999-09-17 |
CO4990994A1 (es) | 2000-12-26 |
WO1999005106A8 (fr) | 1999-04-15 |
EP0998458A1 (fr) | 2000-05-10 |
ZA986633B (en) | 1999-06-15 |
AR014900A1 (es) | 2001-04-11 |
WO1999005106A1 (fr) | 1999-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2430410A1 (fr) | Phenethanolamines et compositions pharmaceutiques en contenant | |
TNSN96161A1 (fr) | Derives de la quinoleine et de quinazoline nouveaux procede pour leur preparation et formulations pharmaceutiques les contenant. | |
NO170280C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater | |
DE59109082D1 (de) | Mono-N-substituierte 1,4,7,10-Tetraazacyclododecan-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
FR2435471A1 (fr) | Derives de dihydropyridine, procedes d'obtention et compositions pharmaceutiques en contenant | |
NZ240189A (en) | Aryl substituted amides, carbamates, carbonates, ketones and esters; preparation and pharmaceutical/cosmetic compositions thereof | |
TNSN96085A1 (fr) | Amides therapeutiques et compositions les contenant | |
NZ236589A (en) | A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions | |
ES480850A1 (es) | Procedimiento para preparar hidantoinas. | |
ATE60759T1 (de) | Bisdimethoxymethyl(trimethoxybenzyl)isochinolinium salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
FR2354091A1 (fr) | Utilisation d'esters aliphatiques d'acide 2-methyl-2-alkylalcanoiques comme matieres aromatiques et compositions de parfums en contenant | |
ES8207169A1 (es) | Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad. | |
TNSN98210A1 (fr) | Trifluoromethylethers cycliques a fonction piperidinylaminomethyle, procede pour leur preparation et compositions pharmaceutiques les contenant | |
ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
ATE18549T1 (de) | 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
FR2445329A1 (fr) | Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament | |
CA2107485A1 (fr) | Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
FR2707089B1 (fr) | Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
OA09349A (fr) | "Nouveaux dérivés du 3-aminochromane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". | |
TNSN98138A1 (fr) | Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse | |
BE878020A (fr) | Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant | |
FR2421613A1 (fr) | Compositions contenant des benzamides de 3-aminopyrrolidines et leur utilisation therapeutique pour le traitement des allergies | |
OA09665A (fr) | Esters d'aminoacides de l'hydroquinone, leur procédé de préparation et compositions pharmaceutiques ou cosmétiques les contenant | |
ATE7224T1 (de) | Propanolamin-derivate, ihre salze, verfahren zu ihrer herstellung und pharmazeutische praeparate. | |
BE1002181A3 (fr) | 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances. |